HOPE From the Cerebellum: TMS-Induced Cognitive Recovery After Stroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorZi-Xiao Li
About this trial
The objective of this clinical trial is to investigate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in the cerebellum for individuals with post-stroke cognitive impairment. Participants will undergo rTMS in the cerebellar hemisphere opposite the lesion site, once daily for a total of five days.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
iTBS group
DeviceiTBS on the contralesional cerebellum, twice a day for seven days
control group
Deviceshame stimulation on the contralesional cerebellum, twice a day for seven days
Treatment groups
70 Participants
are divided into 2 treatment groupsGroup A: iTBS groupExperimental treatment 1 intervention
Group B: control groupPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
The efficacy of improving cognitive function of post-stroke cognitive impairment
The change of MoCA between baseline and 3 months follow-up
Time frame
3 months follow-up after treatmentSecondary outcomes
1
The safety of improving cognitive function of post-stroke cognitive impairment
Incidence of epilepsy during treatment
Time frame
day1-day7Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Zi-Xiao Li
Lead sponsor
Beijing Tiantan Hospital
Sponsor institution
Source ClinicalTrials.gov